dr. jones on the safety of venetoclax in cll
Published 7 years ago • 218 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:16
dr. jones on the efficacy of venetoclax in relapsed/refractory cll
-
1:31
dr. jeffrey jones on the efficacy of venetoclax in treatment for cll
-
2:12
dr. brander on the safety and efficacy of ibrutinib/venetoclax in cll
-
1:27
dr. jones on studying venetoclax in r/r cll
-
1:28
the benefits of venetoclax in cll
-
2:05
dr. kahl on the impact of venetoclax in chronic lymphocytic leukemia
-
12:05
venetoclax combinations, safety and efficacy
-
7:10
the role of venetoclax rituximab in cll
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
24:09
update on venetoclax for cll
-
1:51
the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll
-
1:01
dr. abedin on the role of venetoclax plus obinutuzumab in cll
-
6:42
venetoclax rituximab in relapsed cll
-
3:33
investigating the safety and efficacy of re-treating cll patients with venetoclax-based regimens
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
20:43
venetoclax resistance: mechanisms and treatment options
-
1:47
dr. barrientos on the role of acalabrutinib in cll
-
1:36
dr. davids on cost effectiveness of time-limited therapy with venetoclax/obinutuzumab in cll
-
0:56
dr. al-sawaf on continual mrd assessment after venetoclax/obinutuzumab in cll